Lymphedema Treatment Market Size (2024 - 2029)

Lymphedema Treatment Market Analysis

The Lymphedema Treatment Market size is estimated at USD 0.87 billion in 2024, and is expected to reach USD 1.34 billion by 2029, growing at a CAGR of 9% during the forecast period (2024-2029).

The major factors driving the growth of the lymphedema treatment market include the rising number of lymphedema cases, technological advancements, and growing treatment awareness. For instance, according to the data released by the WHO in June 2023, globally, an estimated 25 million men are affected with lymphatic filariasis, and over 15 million people are currently suffering from lymphoedema. In addition, according to the data released by the Lymphatic Education & Research Network in May 2023, up to 250 million people worldwide have lymphedema.

Furthermore, the rising number of lymphedema hospitalization rates coupled with cancer across the world are set to drive the market growth during the forecast period. For instance, as per the data published by the Australian Institute of Health and Welfare (AIHW) in June 2023, the age-standardized rate of hospitalizations for lymphoedema in Australia was 30 per 100,000 population (9,400 hospitalizations) in 2022. As per the same source, some types of lymphoedema are related to cancer treatment, and based on projected new cancer cases for 2022, around 4,100 people with breast cancer and between 1,600 and 5,100 people with melanoma of the skin will go on to develop secondary lymphoedema. Thus, the country's high number of lymphoedema hospitalization rates are estimated to drive market growth during the forecast period.

Moreover, the active involvement of government organizations in fostering lymphatic treatment research worldwide is set to create lucrative market growth opportunities during the forecast period. For instance, in August 2022, the inclusion of Lymphatic Diseases and Lymphedema in the Senate FY 2023 Appropriations bill, specifically within the Peer-Reviewed Medical Research Program (PRMRP), is of enormous consequence for both researchers and the patient community. Aligning the lymphatic diseases and highlighting the potential benefits of lymphatic research opens up opportunities to understand and treat conditions that have systemic impacts on health. This development is expected to drive growth in the lymphatic treatment market by fostering innovative research, leading to new treatments and therapies for these conditions.

Therefore, factors such as the rising prevalence of lymphedema and the active involvement of government organizations in fostering lymphatic treatment research worldwide are set to drive the market growth during the forecast period. However, factors such as limited awareness, access to specialized care, and high treatment costs may restrain the market growth during the forecast period.

Lymphedema Treatment Industry Segmentation

Lymphedema is a chronic medical condition characterized by the abnormal accumulation of lymphatic fluid, typically in the arms or legs, causing swelling and discomfort. Management typically involves comprehensive care to reduce swelling, which includes compression therapy, manual lymphatic drainage, and other treatments. The lymphedema treatment market is segmented by treatment type, type, affected area, end-user, and geography. By treatment type, the market is segmented into compression therapy, surgery, laser therapy, and other treatment types. Other treatment types include drugs, exercise, and manual lymph. By type, the market is segmented into secondary lymphedema and primary lymphedema. By affected area, the market is segmented into lower extremity, upper extremity, and genitalia. By end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. Other end-users include homecare settings and rehabilitation centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across regions. For each segment, the market sizing and forecasts were made on the basis of revenue (USD).